510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K933970Substantially Equivalent

N-Assay Tia Igm

Crestat Diagnostics, Inc., Thousand Oaks CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K933970 is the FDA 510(k) clearance record for N-ASSAY TIA IGM, a class II device, cleared for Crestat Diagnostics, Inc. on under FDA product code CFN (Method, Nephelometric, Immunoglobulins (G, A, M)). FDA records list 29 510(k) clearances for Crestat Diagnostics, Inc., from to . As of , FDA records show no recalls naming K933970.

Clearance record

Decision date
Received
(221 days to decision)
Product code
CFN Method, Nephelometric, Immunoglobulins (G, A, M)
Regulation
21 CFR 866.5510
Device class
Class II
Review panel
Immunology
Applicant
Crestat Diagnostics, Inc. 822 Hampshire Rd., Thousand Oaks CA
510(k) summary
Statement
Third party review
No

Clearances, product code CFN

Trailing 12 months

FDA records hold no clearances under product code CFN in the trailing twelve months.

FDA records show no clearances under product code CFN in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code CFN, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260